What factors influence functional ability in patients with rheumatoid arthritis. Do they alter over time?

Rheumatology

Volumn 44, Issue 9, 2005, Pages 1181-1185

  Plant, Michael J ^a   O'Sullivan, M M ^b   Lewis, P A ^c   Camilleri, J P ^d   Coles, E C ^e   Jessop, J D ^d  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^b BETSI CADWALADR UNIVERSITY HEALTH BOARD   (United Kingdom)

^c University of Bath   (United Kingdom)

^d UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^e CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Follow up studies; Functional ability; HAQ; Radiography; Rheumatoid arthritis

Indexed keywords

AURANOFIN; AUROTHIOMALATE; C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; PENICILLAMINE;

ADULT; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; LARSEN SCORE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORNING STIFFNESS; PRIORITY JOURNAL; QUESTIONNAIRE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; RITCHIE ARTICULAR INDEX; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 24144490694     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh707     Document Type: Article

References (45)

1. Fries JF, Spitz PW, Kraines RG, Holman H. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
2. Van der Heijde D. Impact of rheumatoid arthritis on physical function during the first five years. No longer a question mark? Rheumatology 2000;39:579-80.
3. Wolfe F, Hawley DJ, Cathey MA. Clinical and health status measures over time: Prognosis and outcome assessment in rheumatoid arthritis. J Rheumatol 1991;18:190-7.
4. Wolfe F, Cathey MA. The assessment and prediction of functional disability in rheumatoid arthritis. J Rheumatol 1991;18:1298-306.
5. van Zeben D, Hazes JMW, Zwinderman AH et al. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:822-9.
6. Leigh JP, Fries JF, Parikh N. Severity of disability and duration of disease in rheumatoid arthritis. J Rheumatol 1992;19:1907-11.
7. Gardiner PV, Sykes HR, Hassey GA, Walker DJ. An evaluation of the health assessment questionnaire in longterm longitudinal follow-up of disability in rheumatoid arthritis. Br J Rheumatol 1993;32:724-8.
8. Fries JF, Williams CA, Morfield D, Singh G, Sibley J. Reduction in longterm disability in patients with rheumatoid arthritis by disease-modifying anti-rheumatic drugs-based treatment strategies. Arthritis Rheum 1996;39:616-22.
9. Ward MM, Lubeck D, Leigh JP. Longterm health outcomes of patients with rheumatoid arthritis treated in managed care and fee-for-practice settings. J Rheumatol 1998;25:641-9.
10. Gordon P, West J, Jones H, Gibson T. A 10 year prospective follow-up of patients with rheumatoid arthritis 1986-96. J Rheumatol 2001;28:2409-15.
11. Callahan LF, Pincus T, Huston JW, Brooks RH, Nance EP, Kaye JJ. Measures of activity and damage in rheumatoid arthritis: Depiction of changes and prediction of mortality over 5 years. Arthritis Care Res 1997;10:381-94.
12. Munro R, Hampson R, McEntegart A, Thomson EA, Madhok R, Capell H. Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: Results of a five-year prospective study. Ann Rheum Dis 1998;57:88-93.
13. Drossaers-Bakker KW, de Buck M, van Zeben D, Zwinderman AH, Breedveld FC, Hazes JMW. Longterm course and outcome of functional capacity in rheumatoid arthritis. Arthritis Rheum 1999; 42:1854-60.
14. Uhlig T, Smedstad LM, Vaglum P, Moum T, Gerard N, Kvien TK. The course of rheumatoid arthritis and predictors of psychological, physical and radiographic outcome after 5 years of follow-up. Rheumatology 2000;39:732-41.
15. Young A, Dixey J, Cox N et al. How does functional disability in early rheumatoid arthritis affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS). Rheumatology 2000;39:603-11.
16. Wiles NJ, Scott DGI, Barrett EM et al. Benchmarking: The five-year outcome of rheumatoid arthritis assessed using a pain score, the Health Assessment Questionnaire and the short form-36 (SF-36) in a community and a clinic based sample. Ann Rheum Dis 2001; 60:956-61.
17. Fex E, Jonsson K, Jonsson U, Eberhardt K. Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort. Br J Rheumatol 1996;35:1106-15.
18. Mottonen T, Paimela L, Ahonen J, Helve T, Hannonen P, Leirisalo-Repo M. Outcome in patients with early rheumatoid arthritis treated according to the "sawtooth" strategy. Arthritis Rheum 1996;39:996-1005.
19. Fex E, Larsson B, Nived K, Eberhardt K. Effect of rheumatoid arthritis on work status and social and leisure time activities in patients followed 8 years from onset. J Rheumatol 1998;25:44-50.
20. Wolfe F. A reappraisal of HAQ disability in rheumatoid arthritis. Arthritis Rheum 2000;43:2751-61.
21. Lindquist E, Saxne T, Geborek P, Eberhardt K. Ten year outcome in a cohort of patients with early rheumatoid arthritis: Health status, disease process and damage. Ann Rheum Dis 2002;61:1055-9.
22. Egsmose C, Lund B, Borg G et al. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5-year follow-up of a prospective double-blind placebo controlled study. Arthritis Rheum 1995;22:2208-13.
23. Eberhardt KB, Fex E. Functional impairment and disability in early rheumatoid arthritis - development over 5 years. J Rheumatol 1995;22:1037-42.
24. Wiles NJ, Dunn G, Barrett EM, Silman AJ, Symmons DPM. Associations between demographic and disease-related variables and disability over the first five years of inflammatory polyarthritis: A longitudinal analysis using generalised estimating equations. J Clin Epidemiol 2000;53:988-96.
25. Welsing PMJ, van Gestel AM, Swinkels HL, Kiemeney LALM, van Riel PLCM. The relationship between disease activity, joint destruction and functional capacity in rheumatoid arthritis. Arthritis Rheum 2001:44;2009-17.
26. Verstappen S, Jacobs J, Bijlsma J et al. Five-year follow-up of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year. Arthritis Rheum 2003; 48:1797-807.
27. Maillefert JF, Combe B, Goupille P, Cantagrel A, Dougados M. The 5-yr HAQ disability is related to the first year's changes in the narrowing, rather than erosion score in patients with recent-onset rheumatoid arthritis. Rheumatology 2004;43:79-84.
28. Scott DL, Pugner K, Kaarela K et al. The links between joint damage and disability in rheumatoid arthritis. Rheumatology 2000; 39:122-32.
29. van Leeuwen MA, van der Heijde DMFM, Rijswijk MH et al. Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts and acute phase reactants. J Rheumatol 1994;21:425-9.
30. Kvien TK. Epidemiology of disability in rheumatoid arthritis. Rheumatology 2002;41:121-3.
31. Jessop JD, O'Sullivan MM, Lewis PA et al. A longterm five-year randomised controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis. Br J Rheumatol 1998;37:992-1002.
32. Ritchie DM, Boyle JA, McInnes JM et al. Clinical studies with an articular index for assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;147:393-406.
33. Kirwan JR, Reeback JS. Stanford HAQ modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol 1986; 25:206-9.
34. Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 1977;18:481-91.
35. Plant MJ, Williams AL, O'Sullivan MM, Lewis PA, Coles EC, Jessop JD. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis Rheum 2000;43:1473-7.
36. Potts MK, Brandt KD. Evidence of the validity of the Arthritis Impact Measurement Scales. Arthritis Rheum 1987;30:93-6.
37. Plant MJ, Linton S, Dodd E, Jones PW, Dawes PT. The GALS locomotor screen and disability. Ann Rheum Dis 1993;52:886-90.
38. Kvien TK, Kaasa S, Smedstad LM. Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II: A comparison of the SF-36 with disease specific measures. J Clin Epidemiol 1998;51:1077-86.
39. Kuper H, van Leeuwen MA, van Riel PL et al. Radiographic damage in large joints in rheumatoid arthritis: Relationship with radiographic damage in hands and feet, disease activity and physical disability. Br J Rheumatol 1997;36:855-60.
40. Drossaers-Bakker KW, Kroon HM, Zwinderman AH, Breedveld FC, Hazes JMW. Radiographic damage of large joints in longterm rheumatoid arthritis and its relation to function. Rheumatology 2000;39:998-1003.
41. Molenaar ET, Voskuyl AE, Dijmans BA. Functional disability in relation to radiological damage and disease activity in patients with rheumatoid arthritis in remission. J Rheumatol 2002;29:267-70.
42. Sokka T, Kankainene A, Hannonen P. Scores for functional disability in patients with rheumatoid arthritis are correlated at higher levels with pain scores than with radiographic scores. Arthritis Rheum 2000;43:36-9.
43. Escalente A, del Rincon I. How much disability in rheumatoid arthritis is explained by rheumatoid arthritis? Arthritis Rheum 1999;42:1712-21.
44. Sharpe L, Sensky T, Allard S. The course of depression in recent onset rheumatoid arthritis: The predictive role of disability, illness perceptions, pain and coping. J Psychosom Res 2001;51:713-19.
45. Listing J, Zink A, Hagemann D, Gromnica-Ihle E. Another look at external modifiers of disability in early RA. Arthritis Rheum 2000;43:S155.